Opiant Pharmaceuticals (Nasdaq: OPNT) to Ring The Nasdaq Stock Market Opening Bell
19 Dezember 2017 - 4:00PM
What: Opiant Pharmaceuticals, Inc.
(NASDAQ:OPNT), a specialty pharmaceutical company developing
pharmacological treatments for addictions will visit the Nasdaq
MarketSite in Times Square.
In honor of the occasion, Roger Crystal, M.D., Chief
Executive Officer, will ring the Opening Bell.
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Wednesday, December 20, 2017 – 9:15 a.m.
to 9:30 a.m. ET
Opiant Media Contact:Scott
SchneiderScott.schneider@ketchum.com
Nasdaq MarketSite Media Contact:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Opening
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Open, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market open of your choice.
About Opiant Pharmaceuticals, Inc.Opiant
Pharmaceuticals, Inc. is a specialty pharmaceutical company
developing pharmacological treatments for addictions. NIDA, a
division of the NIH, describes these disorders as chronic relapsing
brain diseases which burden society at both the individual and
community levels. With its innovative opioid antagonist nasal
delivery technology, Opiant is positioned to become a leader in
these treatment markets. Its first product, NARCAN® Nasal Spray, is
approved for marketing in the U.S. and Canada by the company’s
partner, Adapt Pharma Operations Limited. For more information
please visit: www.opiant.com.
About NasdaqNasdaq (Nasdaq:NDAQ) is a leading
global provider of trading, clearing, exchange technology, listing,
information and public company services. Through its diverse
portfolio of solutions, Nasdaq enables customers to plan, optimize
and execute their business vision with confidence, using proven
technologies that provide transparency and insight for navigating
today's global capital markets. As the creator of the world's first
electronic stock market, its technology powers more than 90
marketplaces in 50 countries, and 1 in 10 of the world's securities
transactions. Nasdaq is home to approximately 3,900 total listings
with a market value of approximately $12 trillion. To learn more,
visit: http://business.nasdaq.com
-NDAQA-
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
Von Jul 2023 bis Jul 2024